Liver diseases pose a significant threat to human health.Although effective therapeutic agents exist for some liver diseases,there remains a critical need for advancements in research to address the gaps in treatment ...Liver diseases pose a significant threat to human health.Although effective therapeutic agents exist for some liver diseases,there remains a critical need for advancements in research to address the gaps in treatment options and improve patient outcomes.This article reviews the assessment of Elafibranor's effects on liver fibrosis and intestinal barrier function in a mouse model of alcoholic liver disease(ALD),as reported by Koizumi et al in the World Journal of Gastroenterology.We summarize the impact and mechanisms of Elafibranor on ALD,metabolic-associated fatty liver disease,and cholestatic liver disease based on current research.We also explore its potential as a dual agonist of PPARα/δ,which is undergoing Phase III clinical trials for metabolic-associated steatohepatitis.Our goal is to stimulate further investigation into Elafibranor's use for preventing and treating these liver diseases and to provide insights for its clinical application.展开更多
Liver-gut communication is vital in fatty liver diseases,and gut microbes are the key regulators in maintaining liver homeostasis.Chronic alcohol abuse and persistent overnutrition create dysbiosis in gut ecology,whic...Liver-gut communication is vital in fatty liver diseases,and gut microbes are the key regulators in maintaining liver homeostasis.Chronic alcohol abuse and persistent overnutrition create dysbiosis in gut ecology,which can contribute to fatty liver disease.In this review,we discuss the gut microbial compositional changes that occur in alcoholic and nonalcoholic fatty liver diseases and how this gut microbial dysbiosis and its metabolic products are involved in fatty liver disease pathophysiology.We also summarize the new approaches related to gut microbes that might help in the diagnosis and treatment of fatty liver disease.展开更多
AIM: To evaluate the effects of surgical weight loss (Roux-en-Y gastric bypass with a modified Fobi-Capella technique) on non alcoholic fatty liver disease in obese patients.
With the shift in the definition of disease from non-alcoholic fatty liver disease(NAFLD)to metabolism-associated fatty liver disease(MAFLD),as well as the rapid evolution of pathological classification and therapeuti...With the shift in the definition of disease from non-alcoholic fatty liver disease(NAFLD)to metabolism-associated fatty liver disease(MAFLD),as well as the rapid evolution of pathological classification and therapeutic targets,traditional clinical teaching models face challenges such as outdated guideline updates,disjointed translation of scientific research,and limited skill training.This study proposes a dynamic training model integrating“guidelines,clinical practice,and scientific research.”Through stratified case-based teaching(e.g.,FibroScan simulator and metabolic sand table),dynamic guideline analysis(comparing old and new evidence),and the integration of scientific thinking(visualization of CAND1 protein mechanism),a teaching system that integrates theory and practice is constructed.Innovatively developed smart assistant tools(AI decision support system,VR liver biopsy simulator)and a multi-dimensional evaluation system(deviation analysis of diagnosis and treatment pathways,milestone assessment)are used while emphasizing metabolic medicine integration(continuous glucose monitoring and digital therapy)and ethical privacy protection(federated learning framework).This model aims to cultivate students’evidence-based decision-making skills and scientific research transformation thinking through dynamic knowledge base construction and interdisciplinary collaboration,providing sustainable teaching solutions to cope with the rapid iteration of NAFLD diagnosis and treatment.展开更多
AIM： To evaluate the effects of osthole on fatty liver, and investigate the possible mechanism. METHODS： A quail model with hyperlipidemic fatty liver and rat model with alcoholic fatty liver were set up by feeding ...AIM： To evaluate the effects of osthole on fatty liver, and investigate the possible mechanism. METHODS： A quail model with hyperlipidemic fatty liver and rat model with alcoholic fatty liver were set up by feeding high fat diet and alcohol, respectively. These experimental animals were then treated with osthole 5-20 mg/kg for 6 wk, respectively. Whereafter, the lipid in serum and hepatic tissue, and coefficient of hepatic weight were measured. RESULTS： After treatment with osthole the levels of serum total cholesterol （TC）, triglyceride （TG）, lower density lipoprotein-cholesterol （LDL-C）, coefficient of hepatic weight, and the hepatic tissue contents of TC and TG were significantly decreased. The activity of superoxide dismutase （SOD） in liver was improved. In alcohol-induced fatty liver rats, the level of malondialdehyde （MDA） in liver was decreased. In high fat-induced fatty liver quails, glutathione peroxidase （GSH-PX） in liver was significantly improved. The histological evaluation of liver specimens demonstrated that the osthole dramatically decreased lipid accumulation. CONCLUSION： These results suggested that osthole had therapeutic effects on both alcohol and high fatinduced fatty liver. The mechanism might be associated with its antioxidation.展开更多
Metabolic dysfunction-associated steatotic liver disease,previously known as nonalcoholic fatty liver disease(NAFLD),is becoming increasingly common and is associated with significant morbidity and mortality related t...Metabolic dysfunction-associated steatotic liver disease,previously known as nonalcoholic fatty liver disease(NAFLD),is becoming increasingly common and is associated with significant morbidity and mortality related to both liver and non-liver issues.In its early stages,NAFLD is characterized by immune cell dysregulation,which suggests that immune-targeted therapies could be a viable treatment option for nonalcoholic steatohepatitis.A recent study by Zhu et al.investigated the role of autoantibodies in metabolic dysfunction-associated stea-totic liver disease at various histological stages.While the research provided valuable insights,several methodological concerns are noted,which include the study’s retrospective design,a limited panel of autoantibodies,and a lack of a prospective study design that adequately controls for confounding factors such as age,comorbidities and lifestyle.Furthermore,the interpretation of positive antinuclear antibodies as evidence of autoimmune involvement in NAFLD is questioned due to the possibility of nonspecific immune responses.Recommend-ations to improve the study’s design include conducting prospective studies,implementing more detailed antibody profiling,and adjusting for demographic and clinical factors.Future studies should address these issues to improve the clinical relevance and credibility of findings related to autoimmunity in NAFLD.展开更多
BACKGROUND Acute drug-induced liver injury(DILI)events caused by chronic liver disease are relatively common.Some researchers believe that nonalcoholic fatty liver(NAFL)increases the overall risk of DILI.The clinical ...BACKGROUND Acute drug-induced liver injury(DILI)events caused by chronic liver disease are relatively common.Some researchers believe that nonalcoholic fatty liver(NAFL)increases the overall risk of DILI.The clinical characteristics and prognosis of DILI in the context of NAFL disease(NAFLD)are still unclear.Therefore,hospitalized patients with NAFLD combined with DILI at the Tianjin Second People's Hospital were included in this study.The clinical manifestations,classifications,severities,laboratory indicators,and clinical outcomes of the enrolled patients were analyzed,and the clinical characteristics and prognoses of the NAFL+DILI patients were evaluated.AIM To investigate the clinical characteristics and prognosis of DILI in the context of NAFL.METHODS Eighty-nine patients diagnosed with DILI and 110 patients diagnosed with both DILI and NAFL at the Tianjin Second People's Hospital were enrolled.Clinical data,including demographic characteristics,clinical features,laboratory test results,pathology findings,autoantibody titers,suspected drugs,and outcomes,were collected from the two groups of patients.All enrolled patients were followed up to determine the liver function recovery time.RESULTS Compared with the patients in the DILI group,those in the NAFL+DILI group had higher body mass indices;Controlled Attenuation Parameter scores;and triglyceride,total cholesterol,low-density lipoprotein,and insulin levels.The levels of the cytokines interleukin-4 and complement complement c3(C3)were also greater in the NAFL+DILI group than in the DILI group.The proportions of patients with cholestatic-type DILI(16.4%vs 4.5%),cholestasis seen on pathoscopy(40.9%vs 25.8%),grade 2 or above DILI(48.18%vs 40.45%),and a recovery time for liver function ranging from 90 to 180 days(30.6%vs 15.5%)were greater in the NAFL+DILI group than in the DILI group.All of the abovementioned differences between the groups were statistically significant(P<0.05).The autoantibody positivity rates did not significantly differ between the two groups(P>0.05),and the proportions of patients who progressed to chronic drug hepatitis or autoimmune hepatitis were not significantly different between the two groups(both P>0.05).CONCLUSION In the context of NAFL,DILI is more likely to be cholestatic,with a greater degree of liver injury,a longer recovery time,and more pronounced expression of immune factors.展开更多
Objective:To study the clinical value of combined detection of blood lipids,blood glucose,and liver function in non-alcoholic fatty liver disease.Methods:105 patients with non-alcoholic fatty liver disease treated in ...Objective:To study the clinical value of combined detection of blood lipids,blood glucose,and liver function in non-alcoholic fatty liver disease.Methods:105 patients with non-alcoholic fatty liver disease treated in our hospital from May 2022 to July 2024 were selected as the research subjects.All patients underwent a B-ultrasound examination.According to the severity of the disease,they were divided into group A(mild,n=35),group B(moderate,n=44),and group C(severe,n=26).Another 30 healthy residents who came to the hospital for physical examination during the same period were selected as group D.The differences in blood lipids,blood glucose,and liver function indicators between groups were compared.Results:The triglyceride(TG),total cholesterol(TC),and low-density lipoprotein cholesterol(LDL)levels in groups A,B,and C were higher than those in group D,while the high-density lipoprotein cholesterol(HDL)level was lower(P<0.05).The fasting plasma glucose(FPG)levels in groups B and C were higher than those in group D(P<0.05).The TG,LDL,and FPG levels in groups B and C were higher than those in group A(P<0.05).The TC level in group C was higher than that in group A,while the HDL level was lower(P<0.05).The TC and FPG levels in group C were higher than those in group B(P<0.05).The total bilirubin(TBil),aspartate aminotransferase(AST),and alanine aminotransferase(ALT)levels in groups A,B,and C were higher than those in group D(P<0.05).The TBil and ALT levels in groups B and C were higher than those in group A(P<0.05).The AST level in group C was higher than that in group A(P<0.05).The AST and ALT levels in group C were higher than those in group B(P<0.05).Conclusion:Patients with non-alcoholic fatty liver disease have disordered glucose and lipid metabolism.Blood lipids,blood glucose,and liver function are closely related to the severity of the disease.Strengthening exercise and dietary intervention early on can help control the progression of simple fatty liver disease and reduce the risk of severe liver diseases such as steatohepatitis and cirrhosis.展开更多
This article summarizes the epidemiological characteristics and clinical manifest-ations of nonalcoholic fatty liver disease(NAFLD).The incidence of NAFLD has been increased dramatically and become the leading cause o...This article summarizes the epidemiological characteristics and clinical manifest-ations of nonalcoholic fatty liver disease(NAFLD).The incidence of NAFLD has been increased dramatically and become the leading cause of chronic liver disease worldwide.In addition to its adverse outcomes of liver fibrosis,cirrhosis,and hepatocellular carcinoma,and related complications,NAFLD has recently been found to be associated with the high-risk extrahepatic carcinomas,such as various types of lung cancer(i.e.,lung adenocarcinoma,squamous cell carcinoma,and small cell lung cancer).The presence of hepatic steatosis also predisposes lung cancer to liver metastasis,but has better response to immune checkpoint inhibi-tors.Whether other factors(i.e.,gender,smoking,etc.)are associated with NAFLD and lung cancer remains controversial.We also comment on the reciprocal rela-tionships between NAFLD and components of metabolic syndrome.Most meta-bolic syndrome components are suggested to facilitate lung cancer development via activating insulin/insulin-like growth factor axis.In addition,suppressed anti-tumor immunity and accelerated tumor progression could be attributed to the cell-specific metabolic reprogramming in condition of high-fat diet and related obesity.These findings may reveal the role of NAFLD in pulmonary carcinoma and help develop new treatment strategies for this disease.展开更多
In this editorial,we comment on the article by Zhao et al which highlighted how patients having nonalcoholic fatty liver disease(NAFLD)were more susceptible to drug-induced lung injury(DILI).This article looked at the...In this editorial,we comment on the article by Zhao et al which highlighted how patients having nonalcoholic fatty liver disease(NAFLD)were more susceptible to drug-induced lung injury(DILI).This article looked at the downstream effects of metabolic profiles and biochemical processes after medication and substance use.Although previous studies looked at how NAFLD and DILI were related,there is a lack of information on the consequences of everyday medication and substance use.NAFLD is one of the most common chronic liver diseases wor-ldwide and it has been found to be closely related to metabolic syndrome and cardiovascular disease.The aim of this editorial is to analyze the interaction between NAFLD and DILI,what clinical manifestations can occur and what the prognosis of these patients will be.展开更多
BACKGROUND Type 2 diabetes mellitus(T2DM)is a chronic metabolic disease characterized by combinations of insulin resistance and insulin deficiency.Non-alcoholic fatty liver disease(NAFLD)is emerging as a public health...BACKGROUND Type 2 diabetes mellitus(T2DM)is a chronic metabolic disease characterized by combinations of insulin resistance and insulin deficiency.Non-alcoholic fatty liver disease(NAFLD)is emerging as a public health problem worldwide and affects up to 70%of patients with T2DM.Although patients with T2DM have an increased risk of developing advanced liver disease compared to healthy individuals,varying prevalence rates of NAFLD among patients with T2DM,ranging from 34%to 94%,have been reported.AIM To determine prevalence and identify associated factors of NAFLD among Limbe patients with T2DM and evaluate correlation with glycemic control.METHODS A cross-sectional study was carried out from February to June 2024 among patients with T2DM.Gamma-glutamyl transferase(GGT)activity and serum triglycerides(TGs)were measured by spectrophotometry.NAFLD was diagnosed using the fatty liver index score.Data were analyzed using SPSS version 26.0 for Windows.Student’s t-test was used to compare the means of two groups.The χ^(2) test was applied to determine the association of NAFLD and T2DM.Logistic regression analysis was performed to identify predictors of NAFLD.P<0.05 was considered statistically significant.RESULTS Of the 150 patients with T2DM recruited for this study,63(58%)were females and the majority(84.7%)had good glycemic control(glycated hemoglobin<7%).Prevalence of NAFLD among patients with T2DM was 19%.Patients with NAFLD had significantly elevated levels of TGs,GGT,and increased body mass index and waist circumference compared to those without NAFLD.There was a significant association between NAFLD and glycemic control.Predictive factors of NAFLD among patients with T2DM were vegetable intake of less than three times per week[adjusted odds ratio(aOR):0.131,95%CI:0.020-0.839;P=0.032],central obesity(aOR:0.167,95%CI:0.037-0.748;P=0.019),and metformin treatment for T2DM(aOR:0.167,95%CI:0.037-0.718;P<0.001).CONCLUSION The prevalence of NAFLD in patients with T2DM in Limbe Regional Hospital was 19%.Age,central obesity,metformin use,and infrequent consumption of vegetables were important predictors of NAFLD.展开更多
The recent article by Jiang et al published in World Journal of Gastroenterology reports substantial bidirectional associations between gallstone disease(GSD),non-alcoholic fatty liver disease(NAFLD),and kidney stone ...The recent article by Jiang et al published in World Journal of Gastroenterology reports substantial bidirectional associations between gallstone disease(GSD),non-alcoholic fatty liver disease(NAFLD),and kidney stone disease(KSD),based on multicenter cross-sectional studies and a systematic review with meta-analysis.While the findings have the potential to significantly impact clinical and pre-ventive strategies,several methodological issues merit closer examination.This letter critiques key aspects of the study,including sample population hetero-geneity,potential confounding variables,and the reliance on cross-sectional data that may limit causal inferences.We also discuss the generalizability of these results to broader populations given the study's focus on the Chinese demogra-phic.By addressing these concerns,we suggest a more nuanced interpretation of the associations between GSD,NAFLD,and KSD,advocating for longitudinal studies to validate these findings and enhance their applicability in global health contexts.展开更多
BACKGROUND Non-alcoholic fatty liver disease(NAFLD)is a disease of increasing global prevalence and an important risk factor for the development of insulin resistance,type 2 diabetes,non-alcoholic steatohepatitis and ...BACKGROUND Non-alcoholic fatty liver disease(NAFLD)is a disease of increasing global prevalence and an important risk factor for the development of insulin resistance,type 2 diabetes,non-alcoholic steatohepatitis and hepatocellular carcinoma,but the pathogenesis is not clear.The aim of this study was to explore the role of ILF3 in NAFLD.AIM To investigate the molecular processes through which ILF3 facilitates the advancement of NAFLD by inhibiting the expression of p-AMPK.This exploration seeks to provide new insights into the etiology of NAFLD and evaluate the potential of ILF3 as a diagnostic marker and potential treatment focus for future interventions.METHODS In vitro and in vivo experiments were conducted using HepG2 cells and NAFLD animal models.The effects of ILF3 knockdown on lipid synthesis and triglyceride(TG)secretion were examined by analyzing the expression levels of p-AMPK.Additionally,the roles of ILF3 and the AMPK signaling pathway were verified using techniques such as Western blotting,quantitative reverse transcription PCR,Oil Red O staining,and immunohistochemistry.RESULTS Investigations revealed an increase in ILF3 Levels within both HepG2 cells and animal models of NAFLD,concurrently with a decrease in p-AMPK expression.Knocking down ILF3 activated the AMPK pathway,reducing lipid production and TG secretion in hepatocytes,thereby mitigating the advancement of NAFLD.CONCLUSION ILF3 promotes the evolution of NAFLD by inhibiting the expression of p-AMPK.The knockdown of ILF3 activates the AMPK signaling pathway,alleviating the severity of NAFLD.These findings underscore the function of ILF3 in the pathogenesis of NAFLD and demonstrate its viability as a treatment focus and diagnostic indicator.展开更多
Nonalcoholic fatty liver disease(NAFLD)has emerged as the prevailing chronic liver disease in the pediatric population due to the global obesity pandemic.Evidence shows that prenatal and postnatal exposure to maternal...Nonalcoholic fatty liver disease(NAFLD)has emerged as the prevailing chronic liver disease in the pediatric population due to the global obesity pandemic.Evidence shows that prenatal and postnatal exposure to maternal abnormalities leads to a higher risk of pediatric NAFLD through persistent alterations in developmental programming.Gestational diabetes mellitus(GDM)is a hyperglycemic syndrome which has become the most prevalent complication in pregnant women.An increasing number of both epidemiologic investigations and animal model studies have validated adverse and long-term outcomes in offspring following GDM exposure in utero.Similarly,GDM is considered a crucial risk factor for pediatric NAFLD.This review aimed to summarize currently published studies concerning the inductive roles of GDM in offspring NAFLD de velopment during childhood and adolescence.Dysregulations in hepatic lipid metabolism and gut microbiota in offspring,as well as dysfunctions in the placenta are potential factors in the pathogenesis of GDM-associated pediatric NAFLD.In addition,potentially effective interventions for GDM-associated offspring NAFLD are also discussed in this review.However,most of these therapeutic approaches still require further clinical research for validation.展开更多
Non-alcoholic fatty liver disease(NAFLD)has emerged as a global public health concern,affecting over one-quarter of the global population.It is closely associated with the prevalence of obesity and metabolic syndrome....Non-alcoholic fatty liver disease(NAFLD)has emerged as a global public health concern,affecting over one-quarter of the global population.It is closely associated with the prevalence of obesity and metabolic syndrome.Current treatment options for NAFLD are limited and often have side effects.Traditional Chinese medicine(TCM)offers a promising alternative with its holistic approach and use of multi-component herbal formulations.A recent study explored the potential of the TCM formula,"Fanlian Huazhuo Formula(FLHZF)",to alleviate high-fat dietinduced NAFLD by regulating autophagy and lipid synthesis signaling pathways.TCM has shown advantages in the prevention and treatment of NAFLD due to its efficacy and minimal side effects.However,the complex multicomponent and multitarget characteristics of formulas such as FLHZF present challenges in research.Future studies should focus on utilizing modern techniques to deepen our understanding of the mechanisms of action and active ingredients of Chinese herbal medicines,thereby promoting their modernization.展开更多
Non-alcoholic fatty liver disease(NAFLD)without special drugs shows symptoms of liver fat accumulation and steatosis in patients without alcohol intake.Ultrasound evaluation is a critical method in the early diagnosis...Non-alcoholic fatty liver disease(NAFLD)without special drugs shows symptoms of liver fat accumulation and steatosis in patients without alcohol intake.Ultrasound evaluation is a critical method in the early diagnosis of NAFLD stages as well as image processing and should be encouraged.Olive oil is an important component of the Mediterranean diet and has a beneficial role in the prevention of NAFLD progression.Physical activity and exercise can have anti-oxidant and anti-inflammatory effects to reduce liver fat and body weight via regulation of mitochondrial capacity in the development of NAFLD.Both the Mediterranean diet and physical exercise should be combined to achieve the ideal fat content reduction and weight loss in patients with NAFLD.展开更多
BACKGROUND Non-alcoholic fatty liver disease(NAFLD)is characterized by the accumulation of fat in the liver in individuals who do not consume alcohol.Several risk factors influencing the onset of NAFLD after laparosco...BACKGROUND Non-alcoholic fatty liver disease(NAFLD)is characterized by the accumulation of fat in the liver in individuals who do not consume alcohol.Several risk factors influencing the onset of NAFLD after laparoscopic pancreaticoduodenectomy(LPD)have been identified.This study investigated the risk factors associated with the development of fatty liver after laparoscopic duodenum-preserving pancreatic total head resection(LDPPHRt)and LPD.AIM To compare the effects of LDPPHRt and LPD on the development of postoperative NAFLD.METHODS This retrospective cohort study included 59 patients who were histologically diagnosed with benign or low-grade malignant pancreatic tumors and who underwent laparoscopic pancreatic surgery(LDPPHRt or LPD)between May 2020 and April 2023.Patient data on perioperative and postoperative variables were analyzed and compared.Multivariate logistic regression was used to identify pre-,peri-,and postoperative risk factors for NAFLD,with statistical significance set at P<0.05.RESULTS Of the 59 patients included in the study,17(28.8%)developed NAFLD within 6-12 months post-surgery.The incidence of NAFLD was significantly higher in the LPD group compared to the LDPPHRt group(40.0%vs 12.5%,P=0.022).Multivariable analysis identified the LDPPHRt surgical approach(compared to LPD)as an independent protective factor against the development of postoperative NAFLD,with an odds ratio of 0.208(95%confidence interval:0.046-0.931;P=0.040).CONCLUSION Our findings indicate that LDPPHRt is more effective than LPD in reducing the incidence of postoperative NAFLD,which may inform surgical decision-making and optimize patient outcomes after laparoscopic pancreatic surgery.展开更多
Non-alcoholic fatty liver disease(NAFLD)is a progressive disease.Without effective interventions,NAFLD can gradually develop to non-alcoholic steatohepatitis,fatty liver fibrosis,liver cirrhosis and even hepatocellula...Non-alcoholic fatty liver disease(NAFLD)is a progressive disease.Without effective interventions,NAFLD can gradually develop to non-alcoholic steatohepatitis,fatty liver fibrosis,liver cirrhosis and even hepatocellular carcinoma.It is still to investigate the precise molecular mechanism behind the pathophysiology of NAFLD.Triggering receptor expressed on myeloid cells 2(TREM2)can sense tissue injury and mediate immune remodeling,thereby inducing phagocytosis,lipid metabolism,and metabolic transfer,promoting cell survival and combating inflammatory activation.NAFLD might develop as a result of TREM2's regulatory role.We here briefly summarize the biological characteristics of TREM2 and its functions in the disease progression of NAFLD.Moreover,we propose to broaden the therapeutic strategy for NAFLD by targeting TREM2.展开更多
Non-alcoholic fatty liver disease(NAFLD),a critical global health concern,continues to challenge medical researchers with limited treatment options.This letter examines on the study by Luo et al,demonstrating that vit...Non-alcoholic fatty liver disease(NAFLD),a critical global health concern,continues to challenge medical researchers with limited treatment options.This letter examines on the study by Luo et al,demonstrating that vitamin D 1,25-dihydroxyvitamin D3[1,25(OH)2D3]improves hepatic steatosis in NAFLD by inhibiting M1 macrophage polarization via the vitamin D receptor-peroxisome proliferator-activated receptor gamma signaling pathway.This letter critically appraises these findings,comparing them to similar studies,and discusses their potential implications for treating NAFLD.Furthermore,we highlight future directions,including dose optimization and mechanistic studies.展开更多
Non-alcoholic fatty liver disease(NAFLD)is one of the most common chronic liver diseases worldwide.Gut microbiota and its metabolites alteration are closely related to NAFLD.Nootkatone is an edible flavorant derived f...Non-alcoholic fatty liver disease(NAFLD)is one of the most common chronic liver diseases worldwide.Gut microbiota and its metabolites alteration are closely related to NAFLD.Nootkatone is an edible flavorant derived from grapefruit which has a variety of biological activities.However,the precise mechanisms of nootkatone on NAFLD remains to be defined.Our results showed that nootkatone prevented body weight gain and decreased serum lipid level,hepatic lipogenesis,hepatic proinflammatory cytokines secretion in NAFLD mice.Also,nootkatone attenuated inflammatory response via inhibiting TLR4/NF-κB/NLRP3 pathway.Moreover,nootkatone restored intestinal barrier damage through increasing tight junction proteins and short chain fatty acids contents.Further 16S rRNA sequencing of colonic content suggested that nootkatone recovered the disturbed gut microbiota to improve NAFLD.Spearman correlation analysis between gut microbiota and NAFLD related parameters indicated that nootkatone regulated lipid metabolism and immunity via altering the gut microbiota.In conclusion,these findings revealed that nootkatone alleviated hepatic lipid homeostasis and inflammatory response in NAFLD mice,which associated with intestinal barrier integrity and the regulation of gut microbiota.This study provides new perspectives that nootkatone has efficacy on NAFLD via“gut-liver axis”,and nootkatone is expected to be developed as a functional food additive.展开更多
文摘Liver diseases pose a significant threat to human health.Although effective therapeutic agents exist for some liver diseases,there remains a critical need for advancements in research to address the gaps in treatment options and improve patient outcomes.This article reviews the assessment of Elafibranor's effects on liver fibrosis and intestinal barrier function in a mouse model of alcoholic liver disease(ALD),as reported by Koizumi et al in the World Journal of Gastroenterology.We summarize the impact and mechanisms of Elafibranor on ALD,metabolic-associated fatty liver disease,and cholestatic liver disease based on current research.We also explore its potential as a dual agonist of PPARα/δ,which is undergoing Phase III clinical trials for metabolic-associated steatohepatitis.Our goal is to stimulate further investigation into Elafibranor's use for preventing and treating these liver diseases and to provide insights for its clinical application.
基金Supported by Basic Science Research Program(National Research Foundation of Korea),No.2020R1A6A1A03043026.
文摘Liver-gut communication is vital in fatty liver diseases,and gut microbes are the key regulators in maintaining liver homeostasis.Chronic alcohol abuse and persistent overnutrition create dysbiosis in gut ecology,which can contribute to fatty liver disease.In this review,we discuss the gut microbial compositional changes that occur in alcoholic and nonalcoholic fatty liver diseases and how this gut microbial dysbiosis and its metabolic products are involved in fatty liver disease pathophysiology.We also summarize the new approaches related to gut microbes that might help in the diagnosis and treatment of fatty liver disease.
基金Supported by The Fondo de Investigación Sanitaria del Instituto de Salud Carlos Ⅲ of the Spanish Ministry for Health and Consumer Affairs,No. PI030042,PI030024,PI070079 and PI11/001159
文摘AIM: To evaluate the effects of surgical weight loss (Roux-en-Y gastric bypass with a modified Fobi-Capella technique) on non alcoholic fatty liver disease in obese patients.
文摘With the shift in the definition of disease from non-alcoholic fatty liver disease(NAFLD)to metabolism-associated fatty liver disease(MAFLD),as well as the rapid evolution of pathological classification and therapeutic targets,traditional clinical teaching models face challenges such as outdated guideline updates,disjointed translation of scientific research,and limited skill training.This study proposes a dynamic training model integrating“guidelines,clinical practice,and scientific research.”Through stratified case-based teaching(e.g.,FibroScan simulator and metabolic sand table),dynamic guideline analysis(comparing old and new evidence),and the integration of scientific thinking(visualization of CAND1 protein mechanism),a teaching system that integrates theory and practice is constructed.Innovatively developed smart assistant tools(AI decision support system,VR liver biopsy simulator)and a multi-dimensional evaluation system(deviation analysis of diagnosis and treatment pathways,milestone assessment)are used while emphasizing metabolic medicine integration(continuous glucose monitoring and digital therapy)and ethical privacy protection(federated learning framework).This model aims to cultivate students’evidence-based decision-making skills and scientific research transformation thinking through dynamic knowledge base construction and interdisciplinary collaboration,providing sustainable teaching solutions to cope with the rapid iteration of NAFLD diagnosis and treatment.
文摘AIM： To evaluate the effects of osthole on fatty liver, and investigate the possible mechanism. METHODS： A quail model with hyperlipidemic fatty liver and rat model with alcoholic fatty liver were set up by feeding high fat diet and alcohol, respectively. These experimental animals were then treated with osthole 5-20 mg/kg for 6 wk, respectively. Whereafter, the lipid in serum and hepatic tissue, and coefficient of hepatic weight were measured. RESULTS： After treatment with osthole the levels of serum total cholesterol （TC）, triglyceride （TG）, lower density lipoprotein-cholesterol （LDL-C）, coefficient of hepatic weight, and the hepatic tissue contents of TC and TG were significantly decreased. The activity of superoxide dismutase （SOD） in liver was improved. In alcohol-induced fatty liver rats, the level of malondialdehyde （MDA） in liver was decreased. In high fat-induced fatty liver quails, glutathione peroxidase （GSH-PX） in liver was significantly improved. The histological evaluation of liver specimens demonstrated that the osthole dramatically decreased lipid accumulation. CONCLUSION： These results suggested that osthole had therapeutic effects on both alcohol and high fatinduced fatty liver. The mechanism might be associated with its antioxidation.
文摘Metabolic dysfunction-associated steatotic liver disease,previously known as nonalcoholic fatty liver disease(NAFLD),is becoming increasingly common and is associated with significant morbidity and mortality related to both liver and non-liver issues.In its early stages,NAFLD is characterized by immune cell dysregulation,which suggests that immune-targeted therapies could be a viable treatment option for nonalcoholic steatohepatitis.A recent study by Zhu et al.investigated the role of autoantibodies in metabolic dysfunction-associated stea-totic liver disease at various histological stages.While the research provided valuable insights,several methodological concerns are noted,which include the study’s retrospective design,a limited panel of autoantibodies,and a lack of a prospective study design that adequately controls for confounding factors such as age,comorbidities and lifestyle.Furthermore,the interpretation of positive antinuclear antibodies as evidence of autoimmune involvement in NAFLD is questioned due to the possibility of nonspecific immune responses.Recommend-ations to improve the study’s design include conducting prospective studies,implementing more detailed antibody profiling,and adjusting for demographic and clinical factors.Future studies should address these issues to improve the clinical relevance and credibility of findings related to autoimmunity in NAFLD.
文摘BACKGROUND Acute drug-induced liver injury(DILI)events caused by chronic liver disease are relatively common.Some researchers believe that nonalcoholic fatty liver(NAFL)increases the overall risk of DILI.The clinical characteristics and prognosis of DILI in the context of NAFL disease(NAFLD)are still unclear.Therefore,hospitalized patients with NAFLD combined with DILI at the Tianjin Second People's Hospital were included in this study.The clinical manifestations,classifications,severities,laboratory indicators,and clinical outcomes of the enrolled patients were analyzed,and the clinical characteristics and prognoses of the NAFL+DILI patients were evaluated.AIM To investigate the clinical characteristics and prognosis of DILI in the context of NAFL.METHODS Eighty-nine patients diagnosed with DILI and 110 patients diagnosed with both DILI and NAFL at the Tianjin Second People's Hospital were enrolled.Clinical data,including demographic characteristics,clinical features,laboratory test results,pathology findings,autoantibody titers,suspected drugs,and outcomes,were collected from the two groups of patients.All enrolled patients were followed up to determine the liver function recovery time.RESULTS Compared with the patients in the DILI group,those in the NAFL+DILI group had higher body mass indices;Controlled Attenuation Parameter scores;and triglyceride,total cholesterol,low-density lipoprotein,and insulin levels.The levels of the cytokines interleukin-4 and complement complement c3(C3)were also greater in the NAFL+DILI group than in the DILI group.The proportions of patients with cholestatic-type DILI(16.4%vs 4.5%),cholestasis seen on pathoscopy(40.9%vs 25.8%),grade 2 or above DILI(48.18%vs 40.45%),and a recovery time for liver function ranging from 90 to 180 days(30.6%vs 15.5%)were greater in the NAFL+DILI group than in the DILI group.All of the abovementioned differences between the groups were statistically significant(P<0.05).The autoantibody positivity rates did not significantly differ between the two groups(P>0.05),and the proportions of patients who progressed to chronic drug hepatitis or autoimmune hepatitis were not significantly different between the two groups(both P>0.05).CONCLUSION In the context of NAFL,DILI is more likely to be cholestatic,with a greater degree of liver injury,a longer recovery time,and more pronounced expression of immune factors.
文摘Objective:To study the clinical value of combined detection of blood lipids,blood glucose,and liver function in non-alcoholic fatty liver disease.Methods:105 patients with non-alcoholic fatty liver disease treated in our hospital from May 2022 to July 2024 were selected as the research subjects.All patients underwent a B-ultrasound examination.According to the severity of the disease,they were divided into group A(mild,n=35),group B(moderate,n=44),and group C(severe,n=26).Another 30 healthy residents who came to the hospital for physical examination during the same period were selected as group D.The differences in blood lipids,blood glucose,and liver function indicators between groups were compared.Results:The triglyceride(TG),total cholesterol(TC),and low-density lipoprotein cholesterol(LDL)levels in groups A,B,and C were higher than those in group D,while the high-density lipoprotein cholesterol(HDL)level was lower(P<0.05).The fasting plasma glucose(FPG)levels in groups B and C were higher than those in group D(P<0.05).The TG,LDL,and FPG levels in groups B and C were higher than those in group A(P<0.05).The TC level in group C was higher than that in group A,while the HDL level was lower(P<0.05).The TC and FPG levels in group C were higher than those in group B(P<0.05).The total bilirubin(TBil),aspartate aminotransferase(AST),and alanine aminotransferase(ALT)levels in groups A,B,and C were higher than those in group D(P<0.05).The TBil and ALT levels in groups B and C were higher than those in group A(P<0.05).The AST level in group C was higher than that in group A(P<0.05).The AST and ALT levels in group C were higher than those in group B(P<0.05).Conclusion:Patients with non-alcoholic fatty liver disease have disordered glucose and lipid metabolism.Blood lipids,blood glucose,and liver function are closely related to the severity of the disease.Strengthening exercise and dietary intervention early on can help control the progression of simple fatty liver disease and reduce the risk of severe liver diseases such as steatohepatitis and cirrhosis.
基金Supported by National Science and Technology Major Project of China,No.2023ZD0508700National Natural Science Foundation of China,No.81470859and Program of Taizhou Science and Technology Grant,No.24ywb33.
文摘This article summarizes the epidemiological characteristics and clinical manifest-ations of nonalcoholic fatty liver disease(NAFLD).The incidence of NAFLD has been increased dramatically and become the leading cause of chronic liver disease worldwide.In addition to its adverse outcomes of liver fibrosis,cirrhosis,and hepatocellular carcinoma,and related complications,NAFLD has recently been found to be associated with the high-risk extrahepatic carcinomas,such as various types of lung cancer(i.e.,lung adenocarcinoma,squamous cell carcinoma,and small cell lung cancer).The presence of hepatic steatosis also predisposes lung cancer to liver metastasis,but has better response to immune checkpoint inhibi-tors.Whether other factors(i.e.,gender,smoking,etc.)are associated with NAFLD and lung cancer remains controversial.We also comment on the reciprocal rela-tionships between NAFLD and components of metabolic syndrome.Most meta-bolic syndrome components are suggested to facilitate lung cancer development via activating insulin/insulin-like growth factor axis.In addition,suppressed anti-tumor immunity and accelerated tumor progression could be attributed to the cell-specific metabolic reprogramming in condition of high-fat diet and related obesity.These findings may reveal the role of NAFLD in pulmonary carcinoma and help develop new treatment strategies for this disease.
文摘In this editorial,we comment on the article by Zhao et al which highlighted how patients having nonalcoholic fatty liver disease(NAFLD)were more susceptible to drug-induced lung injury(DILI).This article looked at the downstream effects of metabolic profiles and biochemical processes after medication and substance use.Although previous studies looked at how NAFLD and DILI were related,there is a lack of information on the consequences of everyday medication and substance use.NAFLD is one of the most common chronic liver diseases wor-ldwide and it has been found to be closely related to metabolic syndrome and cardiovascular disease.The aim of this editorial is to analyze the interaction between NAFLD and DILI,what clinical manifestations can occur and what the prognosis of these patients will be.
文摘BACKGROUND Type 2 diabetes mellitus(T2DM)is a chronic metabolic disease characterized by combinations of insulin resistance and insulin deficiency.Non-alcoholic fatty liver disease(NAFLD)is emerging as a public health problem worldwide and affects up to 70%of patients with T2DM.Although patients with T2DM have an increased risk of developing advanced liver disease compared to healthy individuals,varying prevalence rates of NAFLD among patients with T2DM,ranging from 34%to 94%,have been reported.AIM To determine prevalence and identify associated factors of NAFLD among Limbe patients with T2DM and evaluate correlation with glycemic control.METHODS A cross-sectional study was carried out from February to June 2024 among patients with T2DM.Gamma-glutamyl transferase(GGT)activity and serum triglycerides(TGs)were measured by spectrophotometry.NAFLD was diagnosed using the fatty liver index score.Data were analyzed using SPSS version 26.0 for Windows.Student’s t-test was used to compare the means of two groups.The χ^(2) test was applied to determine the association of NAFLD and T2DM.Logistic regression analysis was performed to identify predictors of NAFLD.P<0.05 was considered statistically significant.RESULTS Of the 150 patients with T2DM recruited for this study,63(58%)were females and the majority(84.7%)had good glycemic control(glycated hemoglobin<7%).Prevalence of NAFLD among patients with T2DM was 19%.Patients with NAFLD had significantly elevated levels of TGs,GGT,and increased body mass index and waist circumference compared to those without NAFLD.There was a significant association between NAFLD and glycemic control.Predictive factors of NAFLD among patients with T2DM were vegetable intake of less than three times per week[adjusted odds ratio(aOR):0.131,95%CI:0.020-0.839;P=0.032],central obesity(aOR:0.167,95%CI:0.037-0.748;P=0.019),and metformin treatment for T2DM(aOR:0.167,95%CI:0.037-0.718;P<0.001).CONCLUSION The prevalence of NAFLD in patients with T2DM in Limbe Regional Hospital was 19%.Age,central obesity,metformin use,and infrequent consumption of vegetables were important predictors of NAFLD.
基金Supported by The National Natural Science Foundation of China,No.82074508Fujian Provincial Natural Science Foundation,No.2023J011627+2 种基金Fujian Provincial Health and Wellness Science and Technology Plan Project,No.2023CXB003Xiamen City Support for the Development of Traditional Chinese Medicine Special TCM Scientific Research Project,No.XWZY-2023-0603The Seventh Batch of National Famous Old Traditional Chinese Medicine Experts Experience Heritage Construction Program of National Administration of TCM,No.76(2022).
文摘The recent article by Jiang et al published in World Journal of Gastroenterology reports substantial bidirectional associations between gallstone disease(GSD),non-alcoholic fatty liver disease(NAFLD),and kidney stone disease(KSD),based on multicenter cross-sectional studies and a systematic review with meta-analysis.While the findings have the potential to significantly impact clinical and pre-ventive strategies,several methodological issues merit closer examination.This letter critiques key aspects of the study,including sample population hetero-geneity,potential confounding variables,and the reliance on cross-sectional data that may limit causal inferences.We also discuss the generalizability of these results to broader populations given the study's focus on the Chinese demogra-phic.By addressing these concerns,we suggest a more nuanced interpretation of the associations between GSD,NAFLD,and KSD,advocating for longitudinal studies to validate these findings and enhance their applicability in global health contexts.
基金Supported by the Wuhan Science and Technology Bureau Project,No.2022020801020552(to Zhan T)Wuhan Health and Family Planning Commission Medical Research Project,No.WX20M01(to Tian X).
文摘BACKGROUND Non-alcoholic fatty liver disease(NAFLD)is a disease of increasing global prevalence and an important risk factor for the development of insulin resistance,type 2 diabetes,non-alcoholic steatohepatitis and hepatocellular carcinoma,but the pathogenesis is not clear.The aim of this study was to explore the role of ILF3 in NAFLD.AIM To investigate the molecular processes through which ILF3 facilitates the advancement of NAFLD by inhibiting the expression of p-AMPK.This exploration seeks to provide new insights into the etiology of NAFLD and evaluate the potential of ILF3 as a diagnostic marker and potential treatment focus for future interventions.METHODS In vitro and in vivo experiments were conducted using HepG2 cells and NAFLD animal models.The effects of ILF3 knockdown on lipid synthesis and triglyceride(TG)secretion were examined by analyzing the expression levels of p-AMPK.Additionally,the roles of ILF3 and the AMPK signaling pathway were verified using techniques such as Western blotting,quantitative reverse transcription PCR,Oil Red O staining,and immunohistochemistry.RESULTS Investigations revealed an increase in ILF3 Levels within both HepG2 cells and animal models of NAFLD,concurrently with a decrease in p-AMPK expression.Knocking down ILF3 activated the AMPK pathway,reducing lipid production and TG secretion in hepatocytes,thereby mitigating the advancement of NAFLD.CONCLUSION ILF3 promotes the evolution of NAFLD by inhibiting the expression of p-AMPK.The knockdown of ILF3 activates the AMPK signaling pathway,alleviating the severity of NAFLD.These findings underscore the function of ILF3 in the pathogenesis of NAFLD and demonstrate its viability as a treatment focus and diagnostic indicator.
基金supported by grants from the National Nat-ural Science Foundation of China(82170593)National Key R&D Program of China(2021YFC2700802)Collaborative Innovation Program of Shanghai Municipal Health Commission(2020CXJQ01)。
文摘Nonalcoholic fatty liver disease(NAFLD)has emerged as the prevailing chronic liver disease in the pediatric population due to the global obesity pandemic.Evidence shows that prenatal and postnatal exposure to maternal abnormalities leads to a higher risk of pediatric NAFLD through persistent alterations in developmental programming.Gestational diabetes mellitus(GDM)is a hyperglycemic syndrome which has become the most prevalent complication in pregnant women.An increasing number of both epidemiologic investigations and animal model studies have validated adverse and long-term outcomes in offspring following GDM exposure in utero.Similarly,GDM is considered a crucial risk factor for pediatric NAFLD.This review aimed to summarize currently published studies concerning the inductive roles of GDM in offspring NAFLD de velopment during childhood and adolescence.Dysregulations in hepatic lipid metabolism and gut microbiota in offspring,as well as dysfunctions in the placenta are potential factors in the pathogenesis of GDM-associated pediatric NAFLD.In addition,potentially effective interventions for GDM-associated offspring NAFLD are also discussed in this review.However,most of these therapeutic approaches still require further clinical research for validation.
文摘Non-alcoholic fatty liver disease(NAFLD)has emerged as a global public health concern,affecting over one-quarter of the global population.It is closely associated with the prevalence of obesity and metabolic syndrome.Current treatment options for NAFLD are limited and often have side effects.Traditional Chinese medicine(TCM)offers a promising alternative with its holistic approach and use of multi-component herbal formulations.A recent study explored the potential of the TCM formula,"Fanlian Huazhuo Formula(FLHZF)",to alleviate high-fat dietinduced NAFLD by regulating autophagy and lipid synthesis signaling pathways.TCM has shown advantages in the prevention and treatment of NAFLD due to its efficacy and minimal side effects.However,the complex multicomponent and multitarget characteristics of formulas such as FLHZF present challenges in research.Future studies should focus on utilizing modern techniques to deepen our understanding of the mechanisms of action and active ingredients of Chinese herbal medicines,thereby promoting their modernization.
基金Supported by the Natural Science Foundation of Shanghai,No.17ZR1431400National Key Research and Development Program of China,No.2017YFA0103902.
文摘Non-alcoholic fatty liver disease(NAFLD)without special drugs shows symptoms of liver fat accumulation and steatosis in patients without alcohol intake.Ultrasound evaluation is a critical method in the early diagnosis of NAFLD stages as well as image processing and should be encouraged.Olive oil is an important component of the Mediterranean diet and has a beneficial role in the prevention of NAFLD progression.Physical activity and exercise can have anti-oxidant and anti-inflammatory effects to reduce liver fat and body weight via regulation of mitochondrial capacity in the development of NAFLD.Both the Mediterranean diet and physical exercise should be combined to achieve the ideal fat content reduction and weight loss in patients with NAFLD.
基金Supported by National Natural Science Foundation of China,No.82273442.
文摘BACKGROUND Non-alcoholic fatty liver disease(NAFLD)is characterized by the accumulation of fat in the liver in individuals who do not consume alcohol.Several risk factors influencing the onset of NAFLD after laparoscopic pancreaticoduodenectomy(LPD)have been identified.This study investigated the risk factors associated with the development of fatty liver after laparoscopic duodenum-preserving pancreatic total head resection(LDPPHRt)and LPD.AIM To compare the effects of LDPPHRt and LPD on the development of postoperative NAFLD.METHODS This retrospective cohort study included 59 patients who were histologically diagnosed with benign or low-grade malignant pancreatic tumors and who underwent laparoscopic pancreatic surgery(LDPPHRt or LPD)between May 2020 and April 2023.Patient data on perioperative and postoperative variables were analyzed and compared.Multivariate logistic regression was used to identify pre-,peri-,and postoperative risk factors for NAFLD,with statistical significance set at P<0.05.RESULTS Of the 59 patients included in the study,17(28.8%)developed NAFLD within 6-12 months post-surgery.The incidence of NAFLD was significantly higher in the LPD group compared to the LDPPHRt group(40.0%vs 12.5%,P=0.022).Multivariable analysis identified the LDPPHRt surgical approach(compared to LPD)as an independent protective factor against the development of postoperative NAFLD,with an odds ratio of 0.208(95%confidence interval:0.046-0.931;P=0.040).CONCLUSION Our findings indicate that LDPPHRt is more effective than LPD in reducing the incidence of postoperative NAFLD,which may inform surgical decision-making and optimize patient outcomes after laparoscopic pancreatic surgery.
基金Supported by Henan Province's"Double First-Class"Creation of Scientific Research in Traditional Chinese Medicine,No.HSRPDFCTCM-2023-7-23 and No.STG-ZYX02-202117National Traditional Chinese Medicine Clinical Research Base Scientific Research Special Project,No.2022JDZX098 and No.2022JDZX114+1 种基金National Natural Science Foundation of China,No.82205086The 9th China Association for Science and Technology Young Talent Support Project,No.2023QNRC001.
文摘Non-alcoholic fatty liver disease(NAFLD)is a progressive disease.Without effective interventions,NAFLD can gradually develop to non-alcoholic steatohepatitis,fatty liver fibrosis,liver cirrhosis and even hepatocellular carcinoma.It is still to investigate the precise molecular mechanism behind the pathophysiology of NAFLD.Triggering receptor expressed on myeloid cells 2(TREM2)can sense tissue injury and mediate immune remodeling,thereby inducing phagocytosis,lipid metabolism,and metabolic transfer,promoting cell survival and combating inflammatory activation.NAFLD might develop as a result of TREM2's regulatory role.We here briefly summarize the biological characteristics of TREM2 and its functions in the disease progression of NAFLD.Moreover,we propose to broaden the therapeutic strategy for NAFLD by targeting TREM2.
基金National Natural Science Foundation of China,No.82170406 and No.81970238.
文摘Non-alcoholic fatty liver disease(NAFLD),a critical global health concern,continues to challenge medical researchers with limited treatment options.This letter examines on the study by Luo et al,demonstrating that vitamin D 1,25-dihydroxyvitamin D3[1,25(OH)2D3]improves hepatic steatosis in NAFLD by inhibiting M1 macrophage polarization via the vitamin D receptor-peroxisome proliferator-activated receptor gamma signaling pathway.This letter critically appraises these findings,comparing them to similar studies,and discusses their potential implications for treating NAFLD.Furthermore,we highlight future directions,including dose optimization and mechanistic studies.
基金supported by grants from National Natural Science Foundation of China(82072709,81902441)Natural Science Foundation of Tianjin Municipal(23JCYBJC00850)+1 种基金China Postdoctoral Science Foundation(2022M712374)Tianjin“131”Innovative Talent Team Project(201926)。
文摘Non-alcoholic fatty liver disease(NAFLD)is one of the most common chronic liver diseases worldwide.Gut microbiota and its metabolites alteration are closely related to NAFLD.Nootkatone is an edible flavorant derived from grapefruit which has a variety of biological activities.However,the precise mechanisms of nootkatone on NAFLD remains to be defined.Our results showed that nootkatone prevented body weight gain and decreased serum lipid level,hepatic lipogenesis,hepatic proinflammatory cytokines secretion in NAFLD mice.Also,nootkatone attenuated inflammatory response via inhibiting TLR4/NF-κB/NLRP3 pathway.Moreover,nootkatone restored intestinal barrier damage through increasing tight junction proteins and short chain fatty acids contents.Further 16S rRNA sequencing of colonic content suggested that nootkatone recovered the disturbed gut microbiota to improve NAFLD.Spearman correlation analysis between gut microbiota and NAFLD related parameters indicated that nootkatone regulated lipid metabolism and immunity via altering the gut microbiota.In conclusion,these findings revealed that nootkatone alleviated hepatic lipid homeostasis and inflammatory response in NAFLD mice,which associated with intestinal barrier integrity and the regulation of gut microbiota.This study provides new perspectives that nootkatone has efficacy on NAFLD via“gut-liver axis”,and nootkatone is expected to be developed as a functional food additive.
